Mutations in the DPH3 promoter were previously described in 42% of BCCs.42 In a recent study, 73/191 (38.2%) BCCs were found to carry DPH3 promoter mutations that were significantly more frequent in BCC patients with a clinical history of cutaneous neoplasms24. The gene discussed is DPH3; the disease is skin basal cell carcinoma.